Lung (Non-Small Cell) Cancer: A151216 (Hematology Oncology Associates)

Alliance A151216: Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)

Objective

The purpose of this research study is to look at lung cancer patients’ tumors that were removed by surgery for certain genetic changes, and to possibly offer these patients a treatment study with drugs that may specifically target tumors that have these genetic changes.

We are interested to see if your tumor tissue might have one of the following two genetic changes:

  • Genetic changes in ALK
  • Genetic changes in EGFR

Related treatment studies are A081105 and E4512.

For more information, please visit the National Cancer Institute.

Principal Investigator(s)
Shobha Chitneni

Clinical Trial Categories

  • Cancer
  • Lung (Non-Small Cell)
Sponsor(s)
Alliance for Clinical Trials in Oncology
Contact
Katy D'Aprile, RN, BSN at 563-355-7733

Location

  • Hematology Oncology Associates of the Quad Cities
    1351 East Kimberly Road
    Suite 100
    Bettendorf, IA 52722

Contact Us

For more information about our research program and IRB, please contact:

Research Support Office
563-421-7955

Email